| 158/01 | LND | IVS9-1G>A | not reported | | (Bertelli et al., 2004) |
| Sevilla | LND | IVS7-2A>G | E8 excluded | | (Puig et al., 2001; Torres et al., 2000) |
| NS* | LND | IVS7-1G>A | E8 excluded | | (Willers et al., 1999) |
| 3/00 | LND | IVS7-1G>A | E8 excluded | | (Bertelli et al., 2004) |
| NS* | LND | IVS7+5G>C | E7 excluded | | (Willers et al., 1999) |
| LN157, JH, CH | LND | IVS7+5G>A | E7 excluded | | (Jinnah et al., 2005) |
| LN67, MP | LND | IVS7+5G>A | E7 excluded | | (Jinnah et al., 2000) |
| RJK 1934 | LND | IVS7+5G>A | E7 excluded | | (Gibbs et al., 1990) |
| NS* | LND | IVS7-9T>A | E8 excluded | | (Yamada et al., 2004) |
| NS* | LND | IVS7+2T>C | E7 excluded, early termination | | (Yamada et al., 2004) |
| DL*** | LND | IVS7+1G>A | E7 excluded | Previously reported as 375 with a different result | (Jinnah et al., 2000) |
| 533-9T>A | LND | IVS7-9T>A | E8 excluded | | (Kim et al., 1997) |
| Patient B | LND | IVS7-9T>G | E8 excluded | | (Mizunuma et al., 2001) |
| AS | LND | IVS8-2A>G | 17 bp of E9 excluded | | (Marcus et al., 1993a) |
| RJK 906, GM 1899 | LND | IVS8-2A>T | 17 bp of E9 excluded | | (Gibbs et al., 1990; Gibbs et al., 1989) |
| 17/00 | LND | IVS8-1G>C | not reported | | (Bertelli et al., 2004) |
| NS* | LND | IVS8-1G>A | 17 bp of E9 excluded | | (Yamada et al., 2004) |
| NS* | LND | IVS8+6T>C | E8 excluded | | (Willers et al., 1999) |
| LN33 | LND | IVS8+6T>C | E8 excluded | | (Jinnah et al., 2000) |
| LN29, JR | LND | IVS8+6T>G | E8 excluded | | (Jinnah et al., 2000) |
| LN-I, Peru | LND | IVS8+5G>T | E8 excluded | | (Jinnah et al., 2000) |
| RJK 888, GM 7092 | LND | IVS8+5G>A | E8 excluded | | (Gibbs et al., 1990; Gibbs et al., 1989) |
| Shinagawa, TS | LND | 538G>A | E8 excluded | | (Fujimori et al., 1994) |
| Patient A | LND | IVS6+1G>C | E6 excluded | | (Mizunuma et al., 2001) |
| Chermside, RW | LND | IVS6+1G>A | E6 excluded, multiple mRNAs | | (Gordon et al., 1991) |
| LN35, CO | LND | 209G>T | exclusion of 208-318 | | (Jinnah et al., 2000) |
| JC | HRND | IVS2+1G>A | E2 excluded | | (Jinnah et al., 2000) |
| 12-jan | LND | IVS2+1G>C | not reported | | (Bertelli et al., 2004) |
| RJK 1760, CB | LND | IVS1-2A>T | E2 excluded | | (Gibbs et al., 1990) |
| LN5, BN | LND | IVS1-2A>G | E2 excluded | | (Jinnah et al., 2000) |
| NS* | LND | IVS1-1G>C | E2 excluded | | (Yamada et al., 2004) |
| CS | HRH | IVS1+47G>T | inclusion of extra sequences in mRNA | | (Gaigl et al., 2001) |
| NS* | LND | IVS1+1G>T | inclusion of IVS1+1 To 49 in mRNA | | (Yamada et al., 2004) |
| LN11B, LR | HRND | IVS1+1G>T | inclusion of IVS1+1 to 49 in mRNA | | (Jinnah et al., 2000; Jinnah et al., 2005) |
| MM | LNV | IVS1+1G>T | inclusion of IVS1+1 to 49 in mRNA | | (Jinnah et al., 2000) |
| Keio | LND | IVS3+1G>T | E3 excluded, multiple mRNAs | | (Yamada et al., 1993) |
| Q109X | LND | 325C>T | E4 excluded | | (Kim et al., 1997) |
| NS* | LND | IVS6+1G>A | E6 excluded, multiple mRNAs | | (Willers et al., 1999) |
| DB | HRND | IVS5+1G>A | aberrant mRNA | | (Jinnah et al., 2000) |
| NS* | LND | IVS5-2A>G | aberrant mRNA | | (Yamada et al., 2004) |
| Richelieu, LN-M | LND | IVS5-1G>A | E6 excluded, 403delG | | (Jinnah et al., 2000) |
| TL | HRH | IVS5+1229A>G | multiple mRNAs | | (Sege-Peterson et al., 1992) |
| Patient 4 | LND | IVS4-1G>A | E5 excluded | | (Mak et al., 2000) |
| JR, RR | LND | IVS4+1G>T | E4 excluded | | (Jinnah et al., 2000) |
| Family 28 | LND | IVS4-2A>C | E5 excluded | | (O'Neill, 2004) |
| LN66, MD | LND | IVS3-2A>G | E4 excluded | | (Jinnah et al., 2000) |
| NS* | LND | IVS3-1G>T | E4 excluded | | (Yamada et al., 2004) |
| JLY | HRND | IVS1+1G>A | inclusion of IVS1+1 to 49 in mRNA | | (Marcus et al., 1993a) |
